⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3163406 | 0.83 | EPHX2 (0.33) | — | |
| SCHEMBL3163694 | 0.83 | EPHX2 (0.33) | — | |
| SCHEMBL425332 | 0.81 | — | — | |
| SCHEMBL718816 | 0.79 | — | — | |
| SCHEMBL28310143 | 0.78 | LMNA (0.35) | — | |
| SCHEMBL544750 | 0.78 | LMNA (0.35) | — | |
| SCHEMBL2528679 | 0.77 | ALDH1A1 (0.38) | — | |
| SCHEMBL2532520 | 0.77 | ALDH1A1 (0.38) | — | |
| SCHEMBL7051625 | 0.75 | — | — | |
| SCHEMBL17707240 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1191 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230303569-A1 | HETEROCYCLIC COMPOUNDS AS THERAPEUTIC AGENTS | ARISAN THERAPEUTICS INC. (US) | 2023-09-28 | — | — | US | claimed |
| EP-4249479-A1 | GLUCOSIDE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Beijing Increase Innovative Drug Co., Ltd. (CN) | 2023-09-27 | — | — | EP | claimed |
| US-11352328-B2 | Heterocyclic compounds for the treatment of arenavirus | ARISAN THERAPEUTICS INC. (US) | 2022-06-07 | — | — | US | claimed |
| CN-114539231-A | Glucoside derivative and preparation method and application thereof | 北京盈科瑞创新药物研究有限公司 | 2022-05-27 | — | — | CN | claimed |
| WO-2022108849-A1 | HETEROCYCLIC COMPOUNDS AS THERAPEUTIC AGENTS | ARISAN THERAPEUTICS INC. (US) | 2022-05-27 | — | — | WO | claimed |
| EP-3433254-B1 | NAPHTHYRIDINES AS INTEGRIN ANTAGONISTS | GLAXOSMITHKLINE IP DEV LTD (GB) | 2020-06-17 | — | — | EP | claimed |
| US-20190308938-A1 | Heterocyclic Compounds for the Treatment of Arenavirus | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2019-10-10 | — | — | US | claimed |
| US-20190112306-A1 | NAPHTHYRIDINES AS INTEGRIN ANTAGONISTS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2019-04-18 | — | — | US | claimed |
| EP-3433254-A1 | NAPHTHYRIDINES AS INTEGRIN ANTAGONISTS | GlaxoSmithKline Intellectual Property Development Limited (GB) | 2019-01-30 | — | — | EP | claimed |
| WO-2018013430-A2 | HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF ARENAVIRUS INFECTION | ARISAN THERAPEUTICS INC. (US) | 2018-01-18 | — | — | WO | claimed |
| WO-2002090447-A1 | DICHROIC MIXTURE | ROLIC AG (CH) | 2002-11-14 | — | — | WO | claimed |
| EP-1256602-A1 | Dichroic mixture | Rolic AG (CH) | 2002-11-13 | — | — | EP | claimed |
| WO-2002017912-A1 | ENDOTHELIN ANTAGONISTS | ABBOTT LABORATORIES (US) | 2002-03-07 | — | — | WO | claimed |
| US-6187504-B1 | PHOTOSENSITIVE BLEND CONTAINING A NAPHTHALENE SULFONIUM SULFONATE DERIVATIVE PHOTOACID GENERATOR, RESIN HAVING ALKALI INSOLUBLE GROUPS CLEAVABLE BY ACID, AN ALKALI SOLUBLE RESIN AND A SOLUBILITY CONTROL AGENT; POSITIVES, RESOLUTION | JSR CORPORATION (JP) | 2001-02-13 | — | — | US | claimed |
| WO-1997031534-A1 | USE OF N-PHOSPHONOMETHYLGLYCINE ESTERS IN AQUEOUS SOLUTION AS HERBICIDES, AND NEW N-PHOSPHONOMETHYLGLYCINE ESTERS | BAYER AKTIENGESELLSCHAFT (DE) | 1997-09-04 | — | — | WO | claimed |
| EP-0323757-B1 | Alkylaminopyrimidine derivative, process for producing the same, and insecticide, acaricide and fungicide containing the same as active ingredient | UBE INDUSTRIES (JP) | 1995-05-10 | — | — | EP | claimed |
| US-5166166-A | Hypotensive agents or treatment of cardiovascular disorders | CASSELLA AKTIENGESELLSCHAFT (DE) | 1992-11-24 | — | — | US | claimed |
| EP-0471232-A1 | 3-Dicyclohexylamino-sydnonimines, method for their preparation and their use | CASSELLA Aktiengesellschaft (DE) | 1992-02-19 | — | — | EP | claimed |
| US-4818766-A | ANTIARRHYTHMIA AGENTS, HYPOTENSIVE AGENTS, TREATMENT OF ANGINA | CIBA-GEIGY CORPORATION (US) | 1989-04-04 | — | — | US | claimed |
| EP-0254682-A1 | Phenoxyaliphatylphenylenoxyalkylesters and -amides | CIBA-GEIGY AG (CH) | 1988-01-27 | — | — | EP | claimed |